1. Home
  2. PASG vs VCIG Comparison

PASG vs VCIG Comparison

Compare PASG & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASG
  • VCIG
  • Stock Information
  • Founded
  • PASG 2017
  • VCIG 2013
  • Country
  • PASG United States
  • VCIG Malaysia
  • Employees
  • PASG N/A
  • VCIG N/A
  • Industry
  • PASG Biotechnology: Pharmaceutical Preparations
  • VCIG Diversified Commercial Services
  • Sector
  • PASG Health Care
  • VCIG Consumer Discretionary
  • Exchange
  • PASG Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • PASG 20.3M
  • VCIG 22.5M
  • IPO Year
  • PASG 2020
  • VCIG 2023
  • Fundamental
  • Price
  • PASG $7.00
  • VCIG $0.45
  • Analyst Decision
  • PASG Strong Buy
  • VCIG
  • Analyst Count
  • PASG 4
  • VCIG 0
  • Target Price
  • PASG $59.25
  • VCIG N/A
  • AVG Volume (30 Days)
  • PASG 34.7K
  • VCIG 8.7M
  • Earning Date
  • PASG 11-12-2025
  • VCIG 11-19-2025
  • Dividend Yield
  • PASG N/A
  • VCIG N/A
  • EPS Growth
  • PASG N/A
  • VCIG N/A
  • EPS
  • PASG N/A
  • VCIG 54.73
  • Revenue
  • PASG N/A
  • VCIG $27,819,290.00
  • Revenue This Year
  • PASG N/A
  • VCIG N/A
  • Revenue Next Year
  • PASG N/A
  • VCIG N/A
  • P/E Ratio
  • PASG N/A
  • VCIG $0.01
  • Revenue Growth
  • PASG N/A
  • VCIG 36.99
  • 52 Week Low
  • PASG $5.12
  • VCIG $0.42
  • 52 Week High
  • PASG $26.60
  • VCIG $176.40
  • Technical
  • Relative Strength Index (RSI)
  • PASG 50.90
  • VCIG 28.90
  • Support Level
  • PASG $6.86
  • VCIG $0.69
  • Resistance Level
  • PASG $7.29
  • VCIG $0.85
  • Average True Range (ATR)
  • PASG 0.47
  • VCIG 0.10
  • MACD
  • PASG -0.03
  • VCIG 0.00
  • Stochastic Oscillator
  • PASG 34.58
  • VCIG 3.51

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

Share on Social Networks: